These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158 [TBL] [Abstract][Full Text] [Related]
4. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134 [TBL] [Abstract][Full Text] [Related]
5. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease. Rauch J; Salem D; Subang R; Kuwana M; Levine JS Front Immunol; 2018; 9():2836. PubMed ID: 30619248 [TBL] [Abstract][Full Text] [Related]
6. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies. Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906 [TBL] [Abstract][Full Text] [Related]
7. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome. Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621 [TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome: 30 years and our contribution. Koike T Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome. Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116 [TBL] [Abstract][Full Text] [Related]
10. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. Vega-Ostertag M; Harris EN; Pierangeli SS Arthritis Rheum; 2004 Sep; 50(9):2911-9. PubMed ID: 15457460 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies and platelets. De Jong A; Ziboh V; Robbins D Curr Rheumatol Rep; 2000 Jun; 2(3):238-45. PubMed ID: 11123065 [TBL] [Abstract][Full Text] [Related]
12. In vitro effect of anti-β₂ glycoprotein I antibodies on P-selectin expression, a marker of platelet activation. Bontadi A; Ruffatti A; Giannini S; Falcinelli E; Tonello M; Hoxha A; Gresele P; Punzi L Reumatismo; 2012 Mar; 64(1):35-9. PubMed ID: 22472781 [TBL] [Abstract][Full Text] [Related]
13. Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α. Hollerbach A; Müller-Calleja N; Canisius A; Orning C; Lackner KJ J Thromb Thrombolysis; 2020 Feb; 49(2):228-234. PubMed ID: 31612355 [TBL] [Abstract][Full Text] [Related]
14. Activation of mTOR is involved in anti-β Xia L; Zhou H; Wang T; Xie Y; Wang T; Wang X; Yan J Thromb Res; 2017 Sep; 157():103-110. PubMed ID: 28734155 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. George J; Blank M; Levy Y; Meroni P; Damianovich M; Tincani A; Shoenfeld Y Circulation; 1998 Mar; 97(9):900-6. PubMed ID: 9521339 [TBL] [Abstract][Full Text] [Related]
16. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907 [TBL] [Abstract][Full Text] [Related]
17. Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries. Zager U; Kveder T; Cučnik S; Božič B; Lunder M Autoimmunity; 2014 Nov; 47(7):438-44. PubMed ID: 24819195 [TBL] [Abstract][Full Text] [Related]
18. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Pierangeli SS; Harris EN Lupus; 2003; 12(7):539-45. PubMed ID: 12892395 [TBL] [Abstract][Full Text] [Related]
19. Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects. Sheng Y; Kandiah DA; Krilis SA Lupus; 1998; 7 Suppl 2():S5-9. PubMed ID: 9814663 [TBL] [Abstract][Full Text] [Related]
20. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]